The new report says that Australia needs to adopt regulation and reimbursement frameworks that incentivise new products, support programs proven to deliver meaningful clinical and commercial outcomes, and procurement processes that recognise, reward and stimulate Australian innovation.
Australia can be a global destination for digital health but only with the right settings
October 19, 2022 Other HealthAustralian Biotech
Latest Video
New Stories
-
Stakeholder backing for another PBS co-pay reduction
March 20, 2025 - - Latest News -
If our own government isn't going to do anything, then we can only hope for intervention
March 20, 2025 - - Latest News -
US price negotiation power reveals a very different approach to patient input
March 20, 2025 - - Latest News -
Brisbane-based drugmaker QBiotics celebrates 25 years since its creation
March 19, 2025 - - Australian Biotech -
Imugene's azer-cel granted FDA Fast Track Designation in blood cancer
March 19, 2025 - - Australian Biotech -
Island raises $2.72 million through exercise of listed options
March 19, 2025 - - Australian Biotech -
All manufacturers decide to participate in the second cycle of US price negotiation
March 19, 2025 - - Latest News